Literature DB >> 27492827

Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.

Masoud Dara1, Ivan Solovic2, Giovanni Sotgiu3, Lia D'Ambrosio4, Rosella Centis5, Richard Tran1, Delia Goletti6, Raquel Duarte7, Stefano Aliberti8, Fernando Maria de Benedictis9, Graham Bothamley10, Tom Schaberg11, Ibrahim Abubakar12, Vitor Teixeira13, Brian Ward13, Christina Gratziou14, Giovanni Battista Migliori15.   

Abstract

No evidence exists on tuberculosis (TB) and latent TB infection (LTBI) management policies among refugees in European countries.A questionnaire investigating screening and management practices among refugees was sent to 38 national TB programme representatives of low and intermediate TB incidence European countries/territories of the WHO European Region.Out of 36 responding countries, 31 (86.1%) reported screening for active TB, 19 for LTBI, and eight (22.2%) reporting outcomes of LTBI treatment. Screening for TB is based on algorithms including different combinations of symptom-based questionnaires, bacteriology and chest radiography and LTBI screening on different combinations of tuberculin skin test and interferon-γ release assays. In 22 (61.1%) countries, TB and LTBI screening are performed in refugee centres. In 22 (61.1%) countries, TB services are organised in collaboration with the private sector. 27 (75%) countries answered that screening for TB is performed as per national and international guidelines, while 19 (52.7%) gave the same answer with regards to LTBI screening. Infection control measures are inadequate in several of the countries surveyed.There is need for improved coordination of TB screening in Europe to implement the End TB Strategy and achieve TB elimination.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27492827     DOI: 10.1183/13993003.00840-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

1.  Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.

Authors:  Ioana Margineanu; Kieran Rustage; Teymur Noori; Dominik Zenner; Christina Greenaway; Manish Pareek; Onno Akkerman; Sally Hayward; Jon S Friedland; Delia Goletti; Ymkje Stienstra; Sally Hargreaves
Journal:  Euro Surveill       Date:  2022-03

Review 2.  Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.

Authors:  Fabrizio Cantini; Carlotta Nannini; Laura Niccoli; Linda Petrone; Giuseppe Ippolito; Delia Goletti
Journal:  Mediators Inflamm       Date:  2017-06-01       Impact factor: 4.711

3.  Delayed diagnosis of severe tuberculous spondylodiscitis in an asylum seeker; patient or doctors delay?

Authors:  Kristina Langholz Kristensen; Daria Podlekareva; Pernille Ravn
Journal:  Respir Med Case Rep       Date:  2017-05-02

4.  A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.

Authors:  Timothy M Walker; Matthias Merker; Astrid M Knoblauch; Peter Helbling; Otto D Schoch; Marieke J van der Werf; Katharina Kranzer; Lena Fiebig; Stefan Kröger; Walter Haas; Harald Hoffmann; Alexander Indra; Adrian Egli; Daniela M Cirillo; Jérôme Robert; Thomas R Rogers; Ramona Groenheit; Anne T Mengshoel; Vanessa Mathys; Marjo Haanperä; Dick van Soolingen; Stefan Niemann; Erik C Böttger; Peter M Keller
Journal:  Lancet Infect Dis       Date:  2018-01-08       Impact factor: 25.071

Review 5.  Migrants' and refugees' health status and healthcare in Europe: a scoping literature review.

Authors:  Adele Lebano; Sarah Hamed; Hannah Bradby; Alejandro Gil-Salmerón; Estrella Durá-Ferrandis; Jorge Garcés-Ferrer; Fabienne Azzedine; Elena Riza; Pania Karnaki; Dina Zota; Athena Linos
Journal:  BMC Public Health       Date:  2020-06-30       Impact factor: 3.295

6.  The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.

Authors:  Christina Greenaway; Manish Pareek; Claire-Nour Abou Chakra; Moneeza Walji; Iuliia Makarenko; Balqis Alabdulkarim; Catherine Hogan; Ted McConnell; Brittany Scarfo; Robin Christensen; Anh Tran; Nick Rowbotham; Marieke J van der Werf; Teymur Noori; Kevin Pottie; Alberto Matteelli; Dominik Zenner; Rachael L Morton
Journal:  Euro Surveill       Date:  2018-04

7.  The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.

Authors:  Christina Greenaway; Manish Pareek; Claire-Nour Abou Chakra; Moneeza Walji; Iuliia Makarenko; Balqis Alabdulkarim; Catherine Hogan; Ted McConnell; Brittany Scarfo; Robin Christensen; Anh Tran; Nick Rowbotham; Teymur Noori; Marieke J van der Werf; Kevin Pottie; Alberto Matteelli; Dominik Zenner; Rachael L Morton
Journal:  Euro Surveill       Date:  2018-04

8.  Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient.

Authors:  P Helbling; S Kröger; W Haas; S Brusin; D M Cirillo; R Groenheit; J-P Guthmann; H Soini; D Hendrickx; M J van der Werf
Journal:  Clin Microbiol Infect       Date:  2018-03-17       Impact factor: 8.067

9.  Tuberculosis Specific Interferon-Gamma Production in a Current Refugee Cohort in Western Europe.

Authors:  Alexandra Jablonka; Christian Dopfer; Christine Happle; Georgios Sogkas; Diana Ernst; Faranaz Atschekzei; Stefanie Hirsch; Annabelle Schäll; Adan Jirmo; Philipp Solbach; Reinhold Ernst Schmidt; Georg M N Behrens; Martin Wetzke
Journal:  Int J Environ Res Public Health       Date:  2018-06-14       Impact factor: 3.390

Review 10.  Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries.

Authors:  D Chemtob; E Ogum
Journal:  Isr J Health Policy Res       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.